A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis. - Wikidata - awgldk - TriplyDB

A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.

A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.

http://www.wikidata.org/entity/Q37866767

about

Natural Products for the Treatment of Chlamydiaceae Infections Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.Host defense peptides: general overview and an update on their activity against Chlamydia spp.The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages.

P2860

Q28066312-D40FDE8F-D243-48A6-BB93-2EBD6CD307FC Q33613788-8281EC07-16A7-4BBC-A0AC-36A923A9B9FB Q36393640-93AEC36A-22D3-47BA-BDA2-7ABB01CC7380 Q37144828-B4506976-539D-423A-BB56-271EC49573D6 Q37845727-2C89D0C9-939B-42B9-A538-A8533F06C4F0 Q37856351-48FF2224-43CA-4E27-BC02-6A103C76B0FB Q38322234-5AD265F5-B14F-48F1-991C-149A6037126B

P2860

A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.

http://www.wikidata.org/entity/Q37866767

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A cumulative experience examin ...... des vs. Chlamydia trachomatis.

@en

A cumulative experience examin ...... des vs. Chlamydia trachomatis.

@nl

type

label

A cumulative experience examin ...... des vs. Chlamydia trachomatis.

@en

A cumulative experience examin ...... des vs. Chlamydia trachomatis.

@nl

prefLabel

A cumulative experience examin ...... des vs. Chlamydia trachomatis.

@en

A cumulative experience examin ...... des vs. Chlamydia trachomatis.

@nl

P1433

Q37866767-035C245A-19D5-4684-AA41-FD4F529B8D66

P1476

Q37866767-BF3E13D1-C2F1-4C5E-94D3-DE3FCFFE80A2

P2093

Q37866767-1B7C03DA-731B-423C-9C0F-4B113A5A33EB

Q37866767-31684BE2-EF5B-4B67-B2D0-923709ED4D0F

Q37866767-DDB9C724-F251-45F6-95AA-BCF4A999D6D3

P2860

Q37866767-030E98DF-A16C-46DA-961A-6D5AF73ED410

Q37866767-0707349F-F1C9-437F-A8E5-555DB1949472

Q37866767-2DD52B0B-0B76-494B-A807-8DA1FDCA77FD

Q37866767-70806570-2DD8-465F-9E69-FFE8D5E2E1DD

Q37866767-94356814-6D10-477D-A7B8-7325B1E4EEF3

Q37866767-95A13ABF-D9B9-4340-8842-4F6A0DF17E80

Q37866767-9626FD5F-E466-4383-94D6-39F623CB6D04

Q37866767-968BC29E-0347-4839-BD89-131C294D592D

Q37866767-C63C0AEB-7380-4BDD-AF2E-9FB0E6201283

Q37866767-CFA35351-08F8-4D41-ABF1-375EA70B9D1A

P304

Q37866767-E228E866-8E6B-48EE-8AF6-7FD83101D890

P31

Q37866767-73517764-68BE-4C59-B694-CDBA8E147EBD

P356

Q37866767-736AB942-9B26-409A-974E-6EC8D276D69A

P433

Q37866767-EC511980-D1DA-46DE-B811-E5500EBB36EC

P478

Q37866767-1E28AA00-7385-4084-A94B-36673C5B8AC9

P577

Q37866767-2A3FF4BA-4C00-41D6-9554-FFD80898E433

P698

Q37866767-F4DEB04A-1C3A-4520-95CB-407E53E6AF28

P921

Q37866767-FF48D20D-8DD9-4248-92E4-94E0329E7907

P356

J.1399-3011.2004.00172.X

P1433

Chemical Biology and Drug Design

P1476

A cumulative experience examin ...... des vs. Chlamydia trachomatis.

@en

P2093

Pang M

http://www.w3.org/2001/XMLSchema#string

Wagar EA

http://www.w3.org/2001/XMLSchema#string

Yasin B

http://www.w3.org/2001/XMLSchema#string

P2860

SMAP-29 has two LPS-binding sites and a central hinge

Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides

hBD-1: a novel beta-defensin from human plasma

Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.

Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria.

Induction of cecropin-like and attacin-like antibacterial but not antiviral activity in Heliothis virescens larvae.

Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.

Neutrophil defensins: purification, characterization, and antimicrobial testing.

P304

65-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-3011.2004.00172.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15251032

http://www.w3.org/2001/XMLSchema#string

P921

Chlamydia trachomatis